Registration - Consultant

Applied Pharmaceutical Innovation / Justin Burrows, Consultant

Registration Information

Client name: Applied Pharmaceutical Innovation
Lobbyist name: Justin Burrows, Consultant
Initial registration start date: 2020-09-09
Registration status: Inactive
Registration Number: 944902-367338

Associated Communications

Total Number of Communication Reports: 3

Monthly communication reports in the last 6 months: 0

Version 1 of 2 (2020-09-09 to 2020-09-22)

Lobbying Information

Subject Matters

Economic Development
Health
Industry
Research and Development

Subject Matter Details

Policies or Program

Looking to address Canada's pharmaceutical supply chain challenges, and expanding Canada's domestic pharmaceutical production.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Employment and Social Development Canada (ESDC)
Health Canada (HC)
Public Health Agency of Canada (PHAC)

Government institutions added through a monthly communication report

Finance Canada (FIN)
Innovation, Science and Economic Development Canada (ISED)

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
3-142C Katz Group Centre
Edmonto, AB T6G 2H7
Canada

Telephone number: 780-860-4494

Client representative

Andrew MacIsaac, Chief Executive Officer

Parent Company Information

Applied Pharmaceutical Innovation is not a subsidiary of any other parent companies.

Coalition Members Information

Applied Pharmaceutical Innovation is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Applied Pharmaceutical Innovation are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Applied Pharmaceutical Innovation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Justin Burrows | Designated public offices held

Business address:
50 O'Connor Street, Suite 1115
Ottawa, ON K1P 6L2
Canada

Telephone number: 613-238-4371

Consultant Firm and Address

Firm: HILL + KNOWLTON STRATEGIES

Address:
50 O'Connor Street, Suite 1115
Ottawa, ON K1P 6L2
Canada

Telephone number: 613-238-4371

Applied Pharmaceutical Innovation/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Applied Pharmaceutical Innovation/	2020-09-09	2020-11-17

Applied Pharmaceutical Innovation

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Justin Burrows, HILL + KNOWLTON STRATEGIES (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-3 of 3

Applied Pharmaceutical Innovation
Consultant: Justin Burrows

Designated Public Office Holders who participated in the communication:
- Terry Duguid, Member of Parliament | House of Commons
- Galen Richardson, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Industry
Communication date: 2020-10-22
Posted date: 2020-11-09
Communication number: 367338-486353 View associated registration
Applied Pharmaceutical Innovation
Consultant: Justin Burrows

Designated Public Office Holders who participated in the communication:
- Helen Broom, Economist/Advisor | Economic Development and Corporate Finance | Finance Canada (FIN)
- Greg Reade, Director General | Economic Development and Corporate Finance | Finance Canada (FIN)
- Richard Botham, Associate Deputy Minister | Economic Development and Corporate Finance | Finance Canada (FIN)
Subject Matter of the communication: Economic Development, Health, Industry, Research and Development
Communication date: 2020-09-22
Posted date: 2020-09-22
Communication number: 367338-482801 View associated registration
Applied Pharmaceutical Innovation
Consultant: Justin Burrows

Designated Public Office Holders who participated in the communication:
- Celine Caira, Policy Advisor | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
- Tim Logan, Policy Advisor | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Research and Development
Communication date: 2020-09-16
Posted date: 2020-09-22
Communication number: 367338-482800 View associated registration

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Policy Advisor Finance Canada, Minister's Office	2013 to 2014	August 28, 2014

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Policy Advisor Finance Canada, Minister's Office	2013 to 2014	August 28, 2014

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Applied Pharmaceutical Innovation / Justin Burrows, Consultant

Registration Information

Associated Communications

Version 1 of 2 (2020-09-09 to 2020-09-22)

Version 1 of 2 (2020-09-09 to 2020-09-22)

Subject Matters

Subject Matter Details

Policies or Program

Communication Techniques

Government Institutions

Government institutions added through a monthly communication report

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address